A&D HOLON Holdings Company, Limited
Fiscal Year Ending March 2026 Q3 Earnings Presentation Materials
For the third quarter of the fiscal year ending March 2026, net sales were 48.6 billion yen (YoY +1.1%), operating income was 5.6 billion yen (YoY -6.7%), and full-year earnings guidance projects net sales of 70 billion yen (vs. prior year +4.3%) and operating income of 9.5 billion yen (vs. prior year +7.8%), expecting increase in both sales and profits.
Key Figures
- Net Sales: 48.632 billion yen (YoY +1.1%)
- Operating Income: 5.648 billion yen (YoY -6.7%)
- Net Income Attributable to Owners of Parent (Quarter): 3.396 billion yen (YoY -14.8%)
AI要約
Overview of Performance
Net sales for the third quarter of the fiscal year ending March 2026 were 48.632 billion yen, a 1.1% increase YoY. Operating income was 5.648 billion yen, a 6.7% decrease YoY. The semiconductor-related business experienced a decline in both sales and profits due to demand adjustment phases, while the measurement and weighing instruments business recorded profit growth due to steady demand and improved profitability. The medical and health equipment business saw sales increase but profits declined due to US tariffs and increased sales costs.
Segment Performance and Full-year Outlook
The semiconductor-related business posted net sales of 8.418 billion yen (YoY -5.7%) and operating income of 2.829 billion yen (YoY -9.0%), showing decreases in sales and profits. The measurement and weighing instruments business reported net sales of 21.315 billion yen (YoY +0.3%) and operating income of 1.593 billion yen (YoY +14.1%), resulting in profit growth. The medical and health equipment business recorded net sales of 18.899 billion yen (YoY +5.4%) and operating income of 2.946 billion yen (YoY -15.5%), experiencing profit decline. The full-year earnings forecast anticipates net sales of 70 billion yen (vs. prior year +4.3%) and operating income of 9.5 billion yen (vs. prior year +7.8%), projecting increases in both sales and profits.
